Synthetic peptides representing the N-terminal segment of surfactant protein C modulate LPS-stimulated TNF-α production by macrophages

Innate Immunity

Volumn 15, Issue 1, 2009, Pages 53-62

  Garcia Verdugo, Ignacio ^a   Garcia de Paco, Elvira ^a   Espinassous, Quentin ^a   Gonzalez Horta, Azucena ^b   Synguelakis, Monique ^a   Kanellopoulos, Jean ^a   Rivas, Luis ^c   Chaby, Richard ^a   Perez Gil, Jesús ^b  

^a INSTITUTE FOR INTEGRATIVE BIOLOGY OF THE CELL I2BC   (France)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Inflammation; LBP; LPS; SP C synthetic peptides; TNF

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; LIPOPEPTIDE; LUNG SURFACTANT; PEPTIDE DERIVATIVE; SURFACTANT PROTEIN C; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DESIGN; FLUORESCENCE; INFLAMMATION; LIPID VESICLE; MACROPHAGE; MOUSE; NONHUMAN; PALMITOYLATION; SEPTIC SHOCK; SERUM;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD14; CELL LINE; LIPOPOLYSACCHARIDES; LIPOSOMES; MACROPHAGES, PERITONEAL; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; PULMONARY SURFACTANTS; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); SUS;

EID: 59749098119     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425908100500     Document Type: Article

References (33)

1. Johansson J. Structure and properties of surfactant protein C. Biochim Biophys Acta 1998; 1408: 161-172.
2. Curstedt T., Johansson J., Persson P. et al. Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. Proc Natl Acad Sci USA 1990; 87: 2985-2989.
3. Pastrana B., Mautone AJ, Mendelsohn R. Fourier transform infrared studies of secondary structure and orientation of pulmonary surfactant SP-C and its effect on the dynamic surface properties of phospholipids. Biochemistry 1991; 30: 10058-10064.
4. Vandenbussche G., Clercx A., Curstedt T. et al. Structure and orientation of the surfactant-associated protein C in a lipid bilayer. Eur J Biochem 1992; 203: 201-209.
5. Morrow MR, Taneva S., Simatos GA et al. NMR studies of the effect of pulmonary surfactant SP-C on the 1,2-dipalmitoyl-snglycero-3-phosphocholine headgroup: A model for transbilayer peptides in surfactant and biological membranes. Biochemistry 1993; 32: 11338-11344.
6. Serrano AG, Perez-Gil J. Protein-lipid interactions and surface activity in the pulmonary surfactant system. Chem Phys Lipids 2006; 141: 105-118.
7. Augusto L., Le Blay K., Auger G. et al. Interaction of bacterial lipopolysaccharide with mouse surfactant protein C inserted into lipid vesicles. Am J Physiol 2001; 281: L776-L785.
8. Augusto LA, Li J., Synguelakis M. et al. Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J Biol Chem 2002; 277: 23484-23492.
9. Augusto LA, Synguelakis M., Espinassous Q. et al. Cellular antiendotoxin activities of lung surfactant protein C in lipid vesicles. Am J Respir Crit Care Med 2003; 168: 335-341.
10. Augusto LA, Synguelakis M., Johansson J. et al. Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide. Infect Immun 2003; 71: 61-67.
11. Miyake K. Innate recognition of lipopolysaccharide by CD14 and Toll-like receptor 4-MD-2: Unique roles for MD-2. Int Immunopharmacol 2003; 3: 119-128.
12. Ulevitch RJ, Tobias PS Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13: 437-457.
13. Hailman E., Lichenstein HS, Wurfel MM et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994; 179: 269-277.
14. Kitchens RL, Thompson PA Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 2005; 11: 225-229.
15. Plasencia I., Rivas L., Casals C. et al. Intrinsic structural differences in the N-terminal segment of pulmonary surfactant protein SP-C from different species. Comp Biochem Physiol A Mol Integr Physiol 2001; 129: 129-139.
16. Plasencia I., Rivas L., Keough KM et al. The N-terminal segment of pulmonary surfactant lipopeptide SP-C has intrinsic propensity to interact with and perturb phospholipid bilayers. Biochem J 2004; 377: 183-193.
17. Plasencia I., Keough KM, Perez-Gil J. Interaction of the N-terminal segment of pulmonary surfactant protein SP-C with interfacial phospholipid films. Biochim Biophys Acta 2005; 1713: 118-128.
18. Plasencia I., Baumgart F., Andreu D. et al. Effect of acylation on the interaction of the N-terminal segment of pulmonary surfactant protein SP-C with phospholipid membranes. Biochim Biophys Acta 2008; 1778: 1274-1282.
19. Perez-Gil J., Cruz A., Casals C. Solubility of hydrophobic surfactant proteins in organic solvent/water mixtures. Structural studies on SP-B and SP-C in aqueous organic solvents and lipids. Biochim Biophys Acta 1993; 1168: 261-270.
20. Curstedt T., Jornvall H., Robertson B. et al. Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity. Eur J Biochem 1987; 168: 255-262.
21. Girard R., Pedron T., Uematsu S. et al. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J Cell Sci 2003; 116: 293-302.
22. Watson J., Riblet R. Genetic control of responses to bacterial lipopolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipopolysaccharides. J Immunol 1975; 114: 1462-1468.
23. Garcia-Verdugo I., Sanchez-Barbero F., Soldau K. et al. Interaction of SP-A (surfactant protein A) with bacterial rough lipopolysaccharide (Re-LPS), and effects of SP-A on the binding of Re-LPS to CD14 and LPS-binding protein. Biochem J 2005; 391: 115-124.
24. Tobias PS, Soldau K., Gegner JA et al. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995; 270: 10482-10488.
25. Schromm AB, Brandenburg K., Rietschel ET et al. Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Lett 1996; 399: 267-271.
26. Tobias PS, Soldau K., Iovine NM et al. Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS. J Biol Chem 1997; 272: 18682-18685.
27. Thomas CJ, Kapoor M., Sharma S. et al. Evidence of a tri-molecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response. FEBS Lett 2002; 531: 184-188.
28. Chaby R. Lipopolysaccharide-binding molecules: Transporters, blockers and sensors. Cell Mol Life Sci 2004; 61: 1697-1713.
29. Lynn WA, Liu Y., Golenbock DT Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide. Infect Immun 1993; 61: 4452-4461.
30. Viriyakosol S., Tobias PS, Kitchens RL et al. MD-2 binds to bacterial lipopolysaccharide. J Biol Chem 2001; 276: 38044-38051.
31. Alcorn JF, Wright JR Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway. Am J Physiol 2004; 286: L129-L136.
32. Mueller M., Brandenburg K., Dedrick R. et al. Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: A role for LPS-binding protein. J Immunol 2005; 174: 1091-1096.
33. Stamme C., Muller M., Hamann L. et al. Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein. Am J Respir Cell Mol Biol 2002; 27: 353-360.